ES469353A1 - Benzimidazole derivative - Google Patents

Benzimidazole derivative

Info

Publication number
ES469353A1
ES469353A1 ES469353A ES469353A ES469353A1 ES 469353 A1 ES469353 A1 ES 469353A1 ES 469353 A ES469353 A ES 469353A ES 469353 A ES469353 A ES 469353A ES 469353 A1 ES469353 A1 ES 469353A1
Authority
ES
Spain
Prior art keywords
butylamino
alkyl
cycloalkyl
formula
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469353A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB18438/77A external-priority patent/GB1595316A/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES469353A1 publication Critical patent/ES469353A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Benzimidazoles of formula (I) and their acid-addition salts are new:- In the formula, R' is H, alkyl or cycloalkyl R2 is alkyl or cycloalkyl R3 is H, primary or secondary alkyl Y is O or S also new are the tautomeric thiols of (I) when Y is S. 16 Cpds. are specifically claimed 4-(2-hydroxy-3-methylaminopropoxy)-2-benzimidazolinone and 1-t-butylamino-3-(2-mercapto-7-methyl-4-benzimidazolyloxy)-2-prop- anol. (I) are beta-blockers with low intrinsic stimulating activity for treating cardiovascular disorders, also having antihypertensive activity. Daily adult dose 5-100 mg. A typical cpd., 4-(3-t-butylamino-2-hydroxypropoxy)-2-benzimidazolinone hydrochloride, was prepd. in 56.3% yield by hydrogenation of 1-t-butylamino-3-(2,3-dinitrophenoxy)-2-propanol and treating the diamino prod. with phosgene.
ES469353A 1977-05-03 1978-05-02 Benzimidazole derivative Expired ES469353A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB18438/77A GB1595316A (en) 1977-05-03 1977-05-03 4-(3-amino-2-hydroxy-propoxy)-benzimidazole derivatives and pharmaceutical compositions containing them
GB4915677 1977-11-25
GB220878 1978-01-19

Publications (1)

Publication Number Publication Date
ES469353A1 true ES469353A1 (en) 1980-01-01

Family

ID=27254036

Family Applications (1)

Application Number Title Priority Date Filing Date
ES469353A Expired ES469353A1 (en) 1977-05-03 1978-05-02 Benzimidazole derivative

Country Status (18)

Country Link
JP (1) JPS53135979A (en)
AR (2) AR220335A1 (en)
AU (1) AU3569678A (en)
DE (1) DE2819458A1 (en)
DK (1) DK190378A (en)
ES (1) ES469353A1 (en)
FI (1) FI781349A (en)
FR (1) FR2399414A1 (en)
GR (1) GR73669B (en)
IL (1) IL54591A0 (en)
IT (1) IT1096276B (en)
LU (1) LU79591A1 (en)
MC (1) MC1192A1 (en)
NL (1) NL7804794A (en)
NO (1) NO781556L (en)
NZ (1) NZ187066A (en)
PT (1) PT67980A (en)
SE (1) SE7805140L (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801980A1 (en) 1978-01-18 1979-07-19 Boehringer Mannheim Gmbh 4-HYDROXY-2-BENZIMIDAZOLINE-THIONE DERIVATIVES, THE PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
EP0003758A1 (en) * 1978-02-09 1979-09-05 Ciba-Geigy Ag Etherified hydroxy-benzodiheterocycles and their acid addition salts, process for their preparation and pharmaceutical compositions containing them
DE2905877A1 (en) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh NEW AMINOPROPANOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
CH661501A5 (en) * 1982-01-26 1987-07-31 Oreal COMPOUNDS DERIVATIVE FROM AMINO-3 PROPANOL-2 FOR USE IN DYEING HAIR, PREPARATION METHOD THEREOF, DYE COMPOSITION CONTAINING THE SAME, AND HAIR DYEING METHOD THEREOF.
DE3839743A1 (en) * 1988-11-25 1990-05-31 Hoechst Ag METHOD FOR PRODUCING BENZIMIDAZOLONES
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
CH559729A5 (en) * 1970-10-23 1975-03-14 Hoechst Ag
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH624395A5 (en) * 1976-01-08 1981-07-31 Ciba Geigy Ag

Also Published As

Publication number Publication date
AU3569678A (en) 1979-11-08
SE7805140L (en) 1978-11-04
LU79591A1 (en) 1979-06-13
PT67980B (en) 1980-05-05
IL54591A0 (en) 1978-07-31
JPS53135979A (en) 1978-11-28
FI781349A (en) 1978-11-04
DK190378A (en) 1978-11-04
FR2399414A1 (en) 1979-03-02
AR220335A1 (en) 1980-10-31
IT7823000A0 (en) 1978-05-03
NL7804794A (en) 1978-11-07
GR73669B (en) 1984-03-28
AR219173A1 (en) 1980-07-31
DE2819458A1 (en) 1978-11-16
MC1192A1 (en) 1979-02-23
PT67980A (en) 1978-06-01
NZ187066A (en) 1981-02-11
IT1096276B (en) 1985-08-26
NO781556L (en) 1978-11-06

Similar Documents

Publication Publication Date Title
ES469353A1 (en) Benzimidazole derivative
JPS5665880A (en) Morpholine derivative
AU4205000A (en) Xanthine derivatives and analogs as cell signaling inhibitors
MX9800483A (en) Piperazine derivatives and their use as 5-ht1a antagonists.
GB1086192A (en) Phenylcyclopropane derivatives
DE69519385D1 (en) CHINAZOLINONE MEDICINES AND THEIR USE
EP0439321A3 (en) Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use
PH30341A (en) Xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas
Szekeres et al. Antiarrhythmic compounds
ES8500884A1 (en) Esters of aryloxypropanolamine derivatives and use as beta-adrenergic blocking agents.
US3558777A (en) Pharmacologic processes and compositions containing azaspirodecanediones and azaspiroundecanediones
DK0737475T3 (en) Use of a muscarinic antagonist for the manufacture of a medicament for the treatment and regulation of ocular development
IE822310L (en) Triazoloquinazolone derivatives
HUT49879A (en) Process for producing new 1',2'-dihydrospiro square brackets open imidazolidine-4,4'(3'h)-quinoline square brackets closed derivatives and pharmaceutical compositions comprising these compounds as active ingredient
UA41329C2 (en) pharmaceutical composition for the treatment of disorders of cardiac rhythm by large mammals and humans, derivatives of 3,7,9,9-tetrazubstituted 3,7-diazabicyclo[3,3,1]nonan and a medicament for the treatment of arrhythmia
IL101506A0 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
NZ332484A (en) use of pyridyl and pyrimidyl substituted piperazine derivatives for treating substance abuse disorders
IE810174L (en) Piperazinyl cycloheptatrienones
GR3000930T3 (en) Pyrido (1,2-a) pyrimidine derivatives
EP0274230A3 (en) Use of 2-oxo-imidazolidine derivatives in the prophylaxis and treatment of heart failure
ES8203380A1 (en) 6-Methyl-4-(1-piperazinyl)-furo(3,2-c)pyridines, process for their preparation and their therapeutic use.
GB1531091A (en) Pharmaceutical combination preparations
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases